نتائج البحث

Economic evaluation of tenofovir disoproxil fumarate prophylaxis to prevent mother-to-child transmission of Hepatitis B virus infection: evidence from a lower-middle income country.

• Authors : Nguyen HT; Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Mahidol University, Bangkok, 10400, Thailand.; University of Health Sciences, Vietnam National University Ho Chi Minh City, Binh Duong City, 820000, Vietnam.

Subjects: Infectious Disease Transmission, Vertical*/Infectious Disease Transmission, Vertical*/Infectious Disease Transmission, Vertical*/prevention & control ; Infectious Disease Transmission, Vertical*/Infectious Disease Transmission, Vertical*/Infectious Disease Transmission, Vertical*/economics ; Tenofovir*/Tenofovir*/Tenofovir*/therapeutic use

• Source: BMC health services research [BMC Health Serv Res] 2024 Dec 28; Vol. 24 (1), pp. 1658. Date of Electronic Publication: 2024 Dec 28.Publisher: BioMed Central Country of Publication: England NLM ID: 101088677 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Protektem pikinini blong yu trial: protocol for a single arm field trial to assess the effectiveness of treating-all pregnant women with hepatitis B infection with tenofovir prophylaxis to prevent mother-to-child transmission in Vanuatu, 2024-2025.

• Authors : Bell L; Burnet Institute, Melbourne, Australia. .; Monash University, Melbourne, Australia. .

Subjects: Infectious Disease Transmission, Vertical*/Infectious Disease Transmission, Vertical*/Infectious Disease Transmission, Vertical*/prevention & control ; Tenofovir*/Tenofovir*/Tenofovir*/therapeutic use ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use

• Source: BMC public health [BMC Public Health] 2024 Dec 18; Vol. 24 (1), pp. 3457. Date of Electronic Publication: 2024 Dec 18.Publisher: BioMed Central Country of Publication: England NLM ID: 100968562 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Effects of tenofovir alafenamide fumarate on serum lipid profiles in patients with chronic hepatitis B.

• Authors : Cao F; Department of Infectious Diseases, Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, No. 321 Zhongshan Road, Nanjing, Jiangsu, 210008, China.; Fan T

Subjects: Tenofovir*/Tenofovir*/Tenofovir*/therapeutic use ; Tenofovir*/Tenofovir*/Tenofovir*/analogs & derivatives ; Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/drug therapy

• Source: Virology journal [Virol J] 2024 Sep 28; Vol. 21 (1), pp. 234. Date of Electronic Publication: 2024 Sep 28.Publisher: BioMed Central Country of Publication: England NLM ID: 101231645 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Functional cure induced by tenofovir alafenamide plus peginterferon-alpha-2b in young children with chronic hepatitis B: a case series study.

• Authors : Zeng QL; Department of Infectious Diseases and Hepatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China. .; Chen RY

Subjects: Tenofovir*/Tenofovir*/Tenofovir*/therapeutic use ; Tenofovir*/Tenofovir*/Tenofovir*/administration & dosage ; Tenofovir*/Tenofovir*/Tenofovir*/analogs & derivatives

• Source: BMC infectious diseases [BMC Infect Dis] 2024 Aug 15; Vol. 24 (1), pp. 830. Date of Electronic Publication: 2024 Aug 15.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Role of tenofovir dipivoxil in gut microbiota recovery from HBV-infection induced dysbiosis.

• Authors : Long J; Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, China.; Saw M

Subjects: Dysbiosis*/Dysbiosis*/Dysbiosis*/microbiology ; Gastrointestinal Microbiome*/Gastrointestinal Microbiome*/Gastrointestinal Microbiome*/drug effects ; Tenofovir*/Tenofovir*/Tenofovir*/therapeutic use

• Source: BMC microbiology [BMC Microbiol] 2024 Sep 20; Vol. 24 (1), pp. 359. Date of Electronic Publication: 2024 Sep 20.Publisher: BioMed Central Country of Publication: England NLM ID: 100966981 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

HIV-1 pretreatment and acquired antiretroviral drug resistance before tenofovir/ /lamivudine /dolutegravir (TLD) roll-out in Mozambique.

• Authors : Ismael N; Instituto Nacional de Saúde, EN1, Bairro da Vila - Parcela N˚3943, Marracuene Sede, Marracuene, Maputo Province, Mozambique. .; Division of Medical Virology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. .

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; HIV Infections*/HIV Infections*/HIV Infections*/virology ; Drug Resistance, Viral*/Drug Resistance, Viral*/Drug Resistance, Viral*/genetics

• Source: BMC infectious diseases [BMC Infect Dis] 2024 Jul 29; Vol. 24 (1), pp. 748. Date of Electronic Publication: 2024 Jul 29.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Pharmacokinetics of tenofovir alafenamide, emtricitabine, and dolutegravir in a patient on peritoneal dialysis.

• Authors : Massih SA; Division of Clinical Pharmacology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Atta MG

Subjects: Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/pharmacokinetics ; Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/therapeutic use ; Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/adverse effects

• Source: AIDS research and therapy [AIDS Res Ther] 2024 May 21; Vol. 21 (1), pp. 34. Date of Electronic Publication: 2024 May 21.Publisher: BioMed Central Country of Publication: England NLM ID: 101237921 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Successful therapy with tenofovir disoproxil fumarate (TDF) in patients with chronic hepatitis B (CHB) does not guarantee amelioration of liver damage assessing by transient elastography. A retrospective - prospective multicenter study.

• Authors : Kranidioti, Hariklia¹ (AUTHOR); Zisimopoulos, Konstantinos² (AUTHOR); Oikonomou, Theodora³ (AUTHOR)

• Source: BMC Gastroenterology. 4/12/2024, Vol. 24 Issue 1, p1-8. 8p.

تفاصيل العنوان

Tenofovir versus entecavir on decreasing risk of HBV-related hepatocellular carcinoma recurrence after liver transplantation.

• Authors : Yang, Jianming¹ (AUTHOR); Chen, Yewu¹ (AUTHOR); Sun, Haobin¹ (AUTHOR)

• Source: Infectious Agents & Cancer. 1/17/2023, Vol. 18 Issue 1, p1-9. 9p.

تفاصيل العنوان

TACE versus TACE + entecavir versus TACE + tenofovir in the treatment of HBV associated hepatocellular carcinoma.

• Authors : Lu, Haohao^1,2 (AUTHOR); Zheng, Chuansheng^1,2 (AUTHOR); Xiong, Bin^1,2 (AUTHOR)

• Source: BMC Cancer. 3/13/2023, Vol. 23 Issue 1, p1-11. 11p.

تفاصيل العنوان